Inflammation

March 2, 2020March 2, 2020

New Blood Test May Aid in Determining Cancerous Ovarian Growths, Study Shows

News

The inflammatory protein interleukin-6 (IL-6) appears at significantly higher levels in the blood of ovarian cancer patients in comparison with women with benign masses in the ovaries and healthy women, ... Read more

May 20, 2019

Ampligen Showing Promise for Recurrent Ovarian Cancer in Phase 1/2 Trial, Phase 2 Study Now Recruiting

News

Hemispherx Biopharma‘s experimental therapy Ampligen (rintatolimod) can change the tumor microenvironment to increase the amount of infiltrating T-cells, an approach that is showing promise in a Phase 1/2 clinical trial ... Read more